EchoSolv AS vs Eko Analysis Software
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your cardiology department or echocardiography lab requires an efficient and accurate AI-powered clinical decision support platform to identify patients at high probability for severe aortic stenosis from existing echocardiogram measurements. This tool is ideal for enhancing workflow by providing ultra-fast risk detection and second reader support, integrating seamlessly with PACS without requiring EMR integration.
View EchoSolv AS →Choose Eko Analysis Software if…
Choose Eko Analysis Software if you are a clinician, particularly in primary care, seeking an AI-powered solution to assist in the early detection of heart murmurs and atrial fibrillation during routine physical examinations. This tool integrates with Eko's digital stethoscopes and mobile app, allowing for wireless auscultation, recording, and analysis of heart sounds and ECGs to aid in proactive cardiovascular care.
View Eko Analysis Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | Eko Analysis Software |
|---|---|---|
| Pricing | Unknown | Freemium with subscription for full features |
| Deployment | Cloud-based | Cloud-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS (Tool A) is designed to integrate seamlessly into existing echocardiography workflows, leveraging PACS without requiring EMR integration, which simplifies deployment and adoption for clinicians. Its measurement-based AI and ultra-fast risk detection (under 3 seconds) further enhance its ease of use within current clinical processes.
Clinical Value
EchoSolv ASEchoSolv AS (Tool A) provides highly accurate, AI-powered clinical decision support specifically for severe aortic stenosis (sAS), a critical condition requiring timely intervention. Its ability to act as a 'second reader' and prioritize studies for closer review offers significant value in improving diagnostic efficiency and patient outcomes for a high-impact disease.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software (Tool B) offers a transparent freemium model with clear subscription tiers for full AI-powered features, making its cost structure accessible and flexible. EchoSolv AS (Tool A) does not provide public pricing information, which is common for enterprise solutions but makes direct comparison on value less transparent.
Enterprise Readiness
EchoSolv ASBoth tools are FDA-cleared, HIPAA compliant, cloud-based, and have BAAs. However, EchoSolv AS (Tool A) explicitly states it integrates with PACS and does not require EMR integration, suggesting a potentially smoother and less disruptive deployment into existing hospital IT infrastructure for imaging departments.
Innovation
Eko Analysis SoftwareEko Analysis Software (Tool B) demonstrates significant innovation by integrating AI with digital stethoscopes and a mobile app for real-time, point-of-care detection of heart murmurs and atrial fibrillation. This approach democratizes advanced cardiovascular screening by bringing diagnostic capabilities directly to the front lines of patient care.
Support & Docs
Eko Analysis SoftwareEko Devices (Tool B) provides a more transparent and accessible support system with dedicated support pages, FAQs, and user manuals readily available on their website. Echo IQ (Tool A), while likely offering direct support channels for its enterprise clients, does not have publicly apparent documentation or a dedicated support portal.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | Eko Analysis Software |
|---|---|---|
| Name | EchoSolv AS | Eko Analysis Software |
| Company | Echo IQ | Eko Devices |
| Description | EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. | Eko Analysis Software is an FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. |
| Primary Focus | Identify high-probability severe aortic stenosis (sAS) patients | Early detection of cardiovascular diseases like heart murmurs and atrial fibrillation |
| Key Features (Examples) | AI-powered clinical decision support for severe aortic stenosis probability, Faster clinical review using standardized, measurement-based AI and guideline analysis, Ultra-fast risk detection (under 3 seconds) | FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Recording, playback, and annotation of heart sounds and ECGs |
| Specialties | Cardiology, Cardiothoracic Surgery | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and Eko Analysis Software.